🇯🇵 XOI in Japan

XOI (XOI) regulatory status in Japan.

Marketing authorisations

PMDA

  • Application: Feburic Initial Approval
  • Local brand name: Feburic Initial Approval
  • Status: approved

Read official source →

PMDA

  • Application: Feburic Partial Change Approval
  • Local brand name: Feburic Partial Change Approval
  • Status: approved

Read official source →

XOI in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Gastroenterology approved in Japan

Frequently asked questions

Is XOI approved in Japan?

Yes. PMDA has authorised it; PMDA has authorised it.

Who is the marketing authorisation holder for XOI in Japan?

Ironwood Pharmaceuticals, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.